| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 345.11B | 341.44B | 322.65B | 319.50B | 349.64B | 300.92B |
| Gross Profit | 72.27B | 71.57B | 65.46B | 87.42B | 124.98B | 88.95B |
| EBITDA | 45.18B | 55.51B | 53.28B | 66.47B | 103.55B | 66.63B |
| Net Income | -4.86B | 2.33B | 8.32B | 23.22B | 54.36B | 28.61B |
Balance Sheet | ||||||
| Total Assets | 584.37B | 573.19B | 579.69B | 503.46B | 474.52B | 404.64B |
| Cash, Cash Equivalents and Short-Term Investments | 85.53B | 78.17B | 102.78B | 87.20B | 92.57B | 84.30B |
| Total Debt | 170.29B | 169.72B | 155.09B | 101.84B | 75.78B | 76.97B |
| Total Liabilities | 270.87B | 254.01B | 249.58B | 184.98B | 174.23B | 160.70B |
| Stockholders Equity | 313.49B | 319.17B | 330.10B | 318.48B | 300.29B | 243.94B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -28.77B | -28.80B | -23.88B | 15.76B | 8.97B |
| Operating Cash Flow | 0.00 | 33.94B | 51.10B | 39.46B | 67.31B | 52.88B |
| Investing Cash Flow | 0.00 | -63.53B | -82.79B | -60.44B | -50.62B | -42.22B |
| Financing Cash Flow | 0.00 | 3.05B | 37.65B | 14.48B | -14.71B | 12.60B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥5.27T | 64.56 | ― | 1.41% | 13.61% | 17.01% | |
73 Outperform | ¥9.48T | 20.30 | 8.95% | 1.88% | 5.02% | 2.02% | |
73 Outperform | ¥69.16B | 33.92 | 3.63% | 2.25% | 9.82% | -50.86% | |
67 Neutral | ¥40.73B | 12.31 | ― | 4.53% | 5.02% | 354.47% | |
67 Neutral | ¥158.27B | 11.45 | ― | 2.18% | -4.77% | -62.32% | |
65 Neutral | ¥771.48B | 15.62 | ― | 2.57% | 5.15% | -47.22% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |